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Abstract
Introduction: The aim of this study was to assess the 
clinical course, etiology and complications of acute 
pancreatitis among chronic kidney disease (CKD) 
patients in a tertiary care renal center in Karachi. 
Methods: We retrospectively evaluated the clinical 
course of CKD patients who presented to our emergency 
room with signs and symptoms of acute pancreatitis over 
a period of two years. 
Results: During the study period, 247 CKD patients 
presented to our emergency room with symptoms 
suggestive of acute pancreatitis. Only 43 patients (17.4%) 
had more than a threefold increase in serum amylase and/
or lipase levels fulfilling the diagnostic criteria of acute 
pancreatitis. They included 25 pre-dialysis CKD patients 
(58.13%) and 18 end stage renal failure patients (41.86%) 
on regular hemodialysis (HD). Among the 25 pre-dialysis 
CKD patients, 17 patients developed acute kidney injury 
(AKI), ten of whom required temporary HD. Twelve of 
those patients (70%) returned back to their baseline renal 
functions after 3-4 weeks. Gallstones were the cause of 
pancreatitis in seven patients (16.3%) while no cause was 
identified in 29 patients (67.4%). Nine patients (20.9%) 
developed multi-organ failure and 12 patients (27.9%) 
required admission to the intensive care unit (ICU). All 
patients survived except for one patient (2.3%) who died 
in the ICU.  patients with less than threefold increase 
in serum amylase and lipase levels responded well to 
conservative management and had a favorable clinical 
course.
Conclusion: In severe acute pancreatitis the mortality 
rate can be as high as 40-58% especially in association 
with comorbid conditions. In this series of CKD patients 
however, the overall mortality rate was 2.3%, probably 
due to the predominance of milder forms of pancreatitis. 
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Introduction
Acute pancreatitis is a condition characterized by 
abdominal pain, nausea and vomiting with elevation of 
pancreatic enzymes in serum [1]. The disease occurs with 
similar frequency among various age groups, but the 
cause of the condition and the likelihood of death vary 
according to age, gender, race and other risk factors. The 
most important risk factors in adults are gallstones and 
excessive alcohol usage [1, 2]. Other causes of pancreatitis 
are metabolic derangements (e.g. hypertriglyceridemia, 
hypercalcemia), viral infection, medications (e.g. 
azathioprine and thiazides), pancreatic duct obstruction 
(e.g. tumors) and trauma. In children, systemic diseases 
are a common cause. In 20% of cases no cause is found 
and these cases are labeled as idiopathic [1]. 
Severe acute pancreatitis is associated with systemic 
complications like organ dysfunction and local 
complications like necrosis, abscess and pseudo cyst 
formation. Mild acute pancreatitis is associated with 
minimal organ dysfunction and lacks the features of severe 
acute pancreatitis [1, 3]. The pathogenesis of pancreatitis 
is due to inappropriate activation of the pro-enzyme 
trypsinogen into the activated enzyme trypsin as well as 
the formation of highly toxic lysolecithin. This results in 
pancreatic injury and inflammation, which can extend 
beyond the organ itself causing multiple organ failure 
and death. The diagnosis depends on typical clinical 
features together with a three-fold elevation of pancreatic 
enzymes. Amylase once elevated returns to normal in 
about 48 to 72 hours. However, increased amylase level 
is found in certain non pancreatic conditions like visceral 
perforation, small bowel ischemia or obstruction and 
ectopic pregnancy. As lipase is predominately secreted 
by the pancreas it is more superior and sensitive in 
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normalization of enzyme level was observed in all of 
them. 
Discussion
An apparent increase in the incidence of acute pancreatitis 
was noticed in the past 40 years in different parts of 
the world. For example, the incidence in Scotland 
has risen from 9.4 per 100,000 per year in 1968-1980 
to 41.9 per 100 000 per year in 1995 [5]. There is a 
likelihood of increasing incidence of acute pancreatitis 
in our part of the world, though the exact incidence is 
not known. Gallstones were the commonest cause of 
acute pancreatitis in our study, which is in accordance 
to different studies from other parts of the world [1]. The 
mortality in patients with acute pancreatitis is associated 
with the number of failing organs and the severity and 
reversibility of the organ dysfunction. In our study, 17 
out of 43 CKD patients developed acute kidney injury; 
ten of whom required temporary HD. Seventy percent of 
those patients eventually recovered their baseline kidney 
function. Early diagnosis and proper management is vital 
in this setting. 
Elevated serum pancreatic enzymes (amylase and lipase) 
are the main tools of diagnosing acute pancreatitis. 
In patients with renal insufficiency, concentration of 
gastrointestinal hormones such as cholecystokinin, 
serum gastric inhibitory peptide, and glucagons are 
significantly increased in relation to degree of renal 
impairment. During long term HD these increased 
hormone concentration do not return to normal. This 
increase in hormone concentrations causes hypersecretion 
of pancreatic enzyme, predominantly trypsin. In the 
absence of acute pancreatitis, plasma concentration of 
amylase and lipase are frequently increased in uremic 
patients and patients on chronic dialysis, both HD and 
peritoneal dialysis. A greater than threefold increase in 
serum amylase and lipase activity together with acute 
onset abdominal pain are generally considered diagnostic 
of acute pancreatitis in CKD patients [6]. Among the 247 
CKD patients included in this study, only 43 (17.4%) 
patients fulfilled this criterion. Another group of patients 
had less than threefold increase in serum enzyme level 
although they presented with typical clinical features of 
acute pancreatitis. Their signs and symptoms subsided and 
enzymes level normalized with conservative treatment. 
It is possible that they had a mild form of pancreatitis 
or other gastrointestinal conditions that responded to 
conservative management. 
The prevalence of acute renal failure alone in severe 
acute pancreatitis is found to be between 5-20%, while 
the incidence of acute renal failure along with other 
complications like respiratory failure, sepsis, and pleural 
effusion is reported between 14-28% in different studies 
from various parts of the world [7-9]. In our study the 
incidence of acute renal failure alone was 25.6% while 
20.9% of patients developed multiple complications 
including acute renal failure. This is in accordance 
with other studies [3, 7-9]. The rationale for antibiotic 
prophylaxis in acute pancreatitis is based on the fact that 
mortality for infected pancreatic necrosis is higher than 
that for sterile necrosis. Randomized controlled trials 
have shown positive effects for the prevention of infected 
pancreatic necrosis and even a reduction in mortality, but 
these effects were not confirmed in all studies [10]. In our 
study, antibiotics were used empirically in 80% of cases. 
Chronic diseases, local complications and the presence of 
organ failure significantly increase the mortality of acute 
pancreatitis. In this study, 60.5% of patients developed 
systemic complications, but the overall mortality was 
only 2.3%. This figure is low compared to a reported 
mortality rate of 40 – 58% in other studies [11-13], and 
diagnosing pancreatitis as compared to amylase [4]. 
Abdominal imaging techniques that are helpful in 
confirming acute pancreatitis or excluding other intra 
abdominal conditions include ultrasound, CT scan and 
MRI. Endoscopic ultrasonography and ERCP are more 
accurate tests for diagnosing and ruling out biliary causes 
of pancreatitis. The aim of this study was to assess the 
etiological factors, severity and the outcome of acute 
pancreatitis in chronic kidney disease (CKD) patients. 
Methods
We retrospectively reviewed the medical records of all 
CKD patients who presented to the Emergency Room of 
the Kidney Center (PGTi), Karachi, Pakistan, between 
January 2006 and April 2008 with signs and symptoms 
suggestive of acute pancreatitis, irrespective of age, 
gender, and comorbidity. Data was collected through 
a data collecting form which included age, gender, 
symptoms at presentation, number of days the patient 
was kept on nil per oral, the highest amylase and lipase 
levels, need for admission to the intensive care unit 
(ICU), number of days spent in the ICU, risk factors for 
development of acute pancreatitis, local and systemic 
complications, ultrasound scan findings, amount of fluid 
given, requirement of hemodialysis (HD), analgesics and 
antibiotics used. The study included patients in various 
CKD stages. All patients presenting with symptoms and 
signs of acute pancreatitis had the following baseline 
investigations: complete blood picture, urea, creatinine, 
electrolytes, calcium, glucose, albumin serum amylase, 
lipase levels and abdominal ultrasound scan. Abdominal 
CT scan was not done due to the risk of inducing contrast 
induced nephropathy in CKD patients. Chronic dialysis 
was defined as regular thrice weekly HD for more than 
six weeks duration. End stage renal failure (ESRF) 
was defined as requirement of chronic dialysis. Acute 
pancreatitis was defined as an episode of acute abdominal 
pain and discomfort with more than threefold increase in 
serum amylase and/or lipase level.
Statistical package for social science (SPSS) version 
17.0 was used for data analysis. Results are presented as 
mean ± standard deviation for quantitative variables and 
percentages for qualitative variables. 
Results
A total of 247 CKD patients presented to our emergency 
room during the study period with symptoms suggestive 
of acute pancreatitis. They included 140 males and 107 
females, with a mean age of 34 ± 6 years (range 18-75). 
Only 43/247 patients (17.4%) fulfilled the diagnostic 
criteria of acute pancreatitis with more than threefold 
increase in serum amylase/lipase levels. The presenting 
complaints of patients ultimately diagnosed to have 
acute pancreatitis are shown in Figure-1. Among those 
43 patients diagnosed as acute pancreatitis, 23 were 
males (53.5%) and 20 were females (46.5%). Twenty-
three patients were diabetic (53.4%), nine patients were 
hypertensive (20.9%) and two patients were alcoholic 
(4.6%). Eighteen patients had ESRF and were maintained 
on regular HD while 25 patients had pre-dialysis CKD. 
Among the 25 pre-dialysis CKD patients diagnosed with 
acute pancreatitis, 17 (68%) developed acute kidney 
injury (AKI) as a complication of acute pancreatitis; ten 
of whom required temporary HD while seven patients 
were managed conservatively. Among the 17 patients 
who developed AKI, 12 patients (70%) returned to their 
baseline kidney function over a period of 3-4 weeks, 
and all patients who required dialysis regained dialysis 
independence. 
Table-1 shows the ultrasound findings at presentation of 
CKD patients diagnosed with acute pancreatitis. Thirty 
patients (69.8%) required various forms of analgesics 
while 13 patients (30.2%) had mild symptoms and 
required no analgesics. Thirty-four patients (79%) were 
given empirical antibiotics. Twenty-six patients (60.5%) 
developed different systemic complications during their 
hospital stay (Figure-2). Twelve patients (27.9%) required 
ICU admission, three of whom remained in the ICU for 
more than a month. All patients survived except for one 
patient (2.3%) who developed severe multi organ failure 
and died in the ICU. Patients with less than threefold 
increase in serum amylase and lipase level were treated 
conservatively; resolution of symptoms and signs with 
Table 1: Ultrasound scan findings at presentation of CKD patients ultimately diagnosed to have acute pancreatitis
Ultrasound findings at presentation Number of patients (%)
Normal ultrasound 29 (67.4%)
Gall stones 7 (16.27%)
Multiple polyps in gall bladder 4 (9.3%)
Edematous wall of gall bladder 3 (7%)
Figure 1: Symptoms at presentation to the emergency 
room of CKD patients ultimately diagnosed to have acute 
pancreatitis
Figure 2: Systemic complications of acute pancreatitis 
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amylase and lipase are frequently increased in uremic 
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CKD patients included in this study, only 43 (17.4%) 
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abdominal conditions include ultrasound, CT scan and 
MRI. Endoscopic ultrasonography and ERCP are more 
accurate tests for diagnosing and ruling out biliary causes 
of pancreatitis. The aim of this study was to assess the 
etiological factors, severity and the outcome of acute 
pancreatitis in chronic kidney disease (CKD) patients. 
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may have resulted from the predominance of milder 
forms of pancreatitis. 
Conclusion
The etiology of acute pancreatitis in this group of patients 
is in accordance to that described in other studies. Despite 
high morbidity, mortality rate was lower than described in 
other studies, which is probably due to the predominance 
of milder forms of pancreatitis. 
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